James Basta

Companies

• Intellia TherapeuticsGeneral counsel Jul 6, 2021 to now¹
• Kura OncologyGeneral counsel Nov 5, 2019 to Jan 28, 2021²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Intellia Therapeutics NTLA156,794 shares³$1.8M at $11.48Mar 2, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Mar 2, 2026Sold 1,211 shares at $13.78 of Intellia Therapeutics³
• Mar 1, 2026Granted 46,080 shares of Intellia Therapeutics³
• Jan 5, 2026Sold 10,397 shares at $9.21 of Intellia Therapeutics⁴
• Mar 4, 2025Sold 2,572 shares at $8.99 of Intellia Therapeutics⁵
• Mar 1, 2025Granted 40,000 shares of Intellia Therapeutics⁵
• Jan 3, 2025Sold 7,074 shares at $12.18 of Intellia Therapeutics⁶
• Mar 4, 2024Sold 2,297 shares at $32.99 of Intellia Therapeutics⁷
• Mar 1, 2024Granted 32,394 shares of Intellia Therapeutics⁷
• Jan 3, 2024Sold 3,805 shares at $29.46 of Intellia Therapeutics⁸
• Mar 2, 2023Sold 1,088 shares at $43.88 of Intellia Therapeutics⁹
• Mar 1, 2023Granted 12,269 shares of Intellia Therapeutics⁹
• Mar 1, 2023Granted 24,539 shares of Intellia Therapeutics⁹
• Jan 4, 2023Sold 1,138 shares at $37.21 of Intellia Therapeutics¹⁰
• Mar 1, 2022Granted 9,648 shares of Intellia Therapeutics¹¹
• Mar 1, 2022Granted 11,049 shares of Intellia Therapeutics¹¹